MYCN and cancer: Our initial findings with the anti-NB efficacy of MYCN/mTOR inhibition on neurospheres and stem cell markers indicate that individual or combined inhibition of MYCN/mTOR might target cancer stem cells - potentially minimizing recurrence of NB.